|
|
||||||||
McConnell Brain Imaging Center, Montréal Neurological Institute, McGill University, Montréal, Québec, Canada
Correspondence: For correspondence or reprints contact: Olivier Rousset, PhD, McConnell Brain Imaging Center, Montréal Neurological Institute, 3801 University Street, Montréal H3A-2B4, Québec, Canada.
ABSTRACT
The accuracy of PET for measuring regional radiotracer concentrations in the human brain is limited by the finite resolution capability of the scanner and the resulting partial volume effects (PVEs). We designed a new algorithm to correct for PVEs by characterizing the geometric interaction between the PET system and the brain activity distribution. Methods: The partial volume correction (PVC) algorithm uses high-resolution volumetric MR images correlated with the PET volume. We used a PET simulator to calculate recovery and cross-contamination factors of identified tissue components in the brain model. These geometry-dependent transfer coefficients forma matrix representing the fraction of true activity from each distinct brain region observed in any given set of regions of interest. This matrix can be inverted to correct for PVEs, independent of the tracer concentrations in each tissue component. A sphere phantom was used to validate the simulated point-spread function of the PET scanner. Accuracy and precision of the PVC method were assessed using a human basal ganglia phantom. A constant contrast experiment was performed to explore the recovery capability and statistic error propagation of PVC in various noise conditions. In addition, a dual isotope experiment was used to evaluate the ability of the PVC algorithm to recover activity concentrations in small structures surrounded by background activity with a different radioactive half-life. This models the time-variable contrast between regions that is often seen in neuroreceptor studies. Results: Data from the three-dimensional brain phantom demonstrated a full recovery capability of PVC with less than 10% root mean-square error in terms of absolute values, which decreased to less than 2% when results from four PET slices were averaged. Inaccuracy in the estimation of 18F tracer half-life in the presence of 11C background activity was in the range of 25%50% before PVC and 0%6% after PVC, for resolution varying from 6 to 14 mm FWHM. In terms of noise propagation, the degradation of the coefficient of variation after PVC was found to be easily predictable and typically on the order of 25%. Conclusion: The PVC algorithm allows the correction for PVEs simultaneously in all identified brain regions, independent of tracer levels.
Key Words: correction partial volume effects PET simulation regions of interest
This article has been cited by other articles:
![]() |
A. Mikhno, D. Devanand, G. Pelton, K. Cuasay, R. Gunn, N. Upton, R. Y. Lai, V. Libri, J. J. Mann, and R. V. Parsey Voxel-Based Analysis of 11C-PIB Scans for Diagnosing Alzheimer's Disease J. Nucl. Med., August 1, 2008; 49(8): 1262 - 1269. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. G. Rousset, D. L. Collins, A. Rahmim, and D. F. Wong Design and Implementation of an Automated Partial Volume Correction in PET: Application to Dopamine Receptor Quantification in the Normal Human Striatum J. Nucl. Med., July 1, 2008; 49(7): 1097 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Villain, B. Desgranges, F. Viader, V. de la Sayette, F. Mezenge, B. Landeau, J.-C. Baron, F. Eustache, and G. Chetelat Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease J. Neurosci., June 11, 2008; 28(24): 6174 - 6181. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Pichler, H. F. Wehrl, and M. S. Judenhofer Latest Advances in Molecular Imaging Instrumentation J. Nucl. Med., June 1, 2008; 49(Suppl_2): 5S - 23S. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chetelat, B. Desgranges, B. Landeau, F. Mezenge, J. B. Poline, V. de la Sayette, F. Viader, F. Eustache, and J.-C. Baron Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease Brain, January 1, 2008; 131(1): 60 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Volkow, G.-J. Wang, J. Newcorn, F. Telang, M. V. Solanto, J. S. Fowler, J. Logan, Y. Ma, K. Schulz, K. Pradhan, et al. Depressed Dopamine Activity in Caudate and Preliminary Evidence of Limbic Involvement in Adults With Attention-Deficit/Hyperactivity Disorder Arch Gen Psychiatry, August 1, 2007; 64(8): 932 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Soret, S. L. Bacharach, and I. Buvat Partial-Volume Effect in PET Tumor Imaging J. Nucl. Med., June 1, 2007; 48(6): 932 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-K. Teo, Y. Seo, S. L. Bacharach, J. A. Carrasquillo, S. K. Libutti, H. Shukla, B. H. Hasegawa, R. A. Hawkins, and B. L. Franc Partial-Volume Correction in PET: Validation of an Iterative Postreconstruction Method with Phantom and Patient Data J. Nucl. Med., May 1, 2007; 48(5): 802 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ciarmiello, M. Cannella, S. Lastoria, M. Simonelli, L. Frati, D. C. Rubinsztein, and F. Squitieri Brain White-Matter Volume Loss and Glucose Hypometabolism Precede the Clinical Symptoms of Huntington's Disease J. Nucl. Med., February 1, 2006; 47(2): 215 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Costes, I. Merlet, K. Ostrowsky, I. Faillenot, F. Lavenne, L. Zimmer, P. Ryvlin, and D. Le Bars A 18F-MPPF PET Normative Database of 5-HT1A Receptor Binding in Men and Women Over Aging J. Nucl. Med., December 1, 2005; 46(12): 1980 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Giovacchini, A. Lerner, M. T. Toczek, C. Fraser, K. Ma, J. C. DeMar, P. Herscovitch, W. C. Eckelman, S. I. Rapoport, and R. E. Carson Brain Incorporation of 11C-Arachidonic Acid, Blood Volume, and Blood Flow in Healthy Aging: A Study With Partial-Volume Correction J. Nucl. Med., September 1, 2004; 45(9): 1471 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Merlet, K. Ostrowsky, N. Costes, P. Ryvlin, J. Isnard, I. Faillenot, F. Lavenne, D. Dufournel, D. Le Bars, and F. Mauguiere 5-HT1A receptor binding and intracerebral activity in temporal lobe epilepsy: an [18F]MPPF-PET study Brain, April 1, 2004; 127(4): 900 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Quarantelli, K. Berkouk, A. Prinster, B. Landeau, C. Svarer, L. Balkay, B. Alfano, A. Brunetti, J.-C. Baron, and M. Salvatore Integrated Software for the Analysis of Brain PET/SPECT Studies with Partial-Volume-Effect Correction J. Nucl. Med., February 1, 2004; 45(2): 192 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Soret, P. M. Koulibaly, J. Darcourt, S. Hapdey, and I. Buvat Quantitative Accuracy of Dopaminergic Neurotransmission Imaging with 123I SPECT J. Nucl. Med., July 1, 2003; 44(7): 1184 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zaidi and B. Hasegawa Determination of the Attenuation Map in Emission Tomography J. Nucl. Med., February 1, 2003; 44(2): 291 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Frouin, C. Comtat, A. Reilhac, and M.-C. Gregoire Correction of Partial-Volume Effect for PET Striatal Imaging: Fast Implementation and Study of Robustness J. Nucl. Med., December 1, 2002; 43(12): 1715 - 1726. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. I. Sheline, M. A. Mintun, S. M. Moerlein, and A. Z. Snyder Greater Loss of 5-HT2A Receptors in Midlife Than in Late Life Am J Psychiatry, March 1, 2002; 159(3): 430 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Feigin, K. L. Leenders, J. R. Moeller, J. Missimer, G. Kuenig, P. Spetsieris, A. Antonini, and D. Eidelberg Metabolic Network Abnormalities in Early Huntington's Disease: An [18F]FDG PET Study J. Nucl. Med., November 1, 2001; 42(11): 1591 - 1595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. de Leon, A. Convit, O. T. Wolf, C. Y. Tarshish, S. DeSanti, H. Rusinek, W. Tsui, E. Kandil, A. J. Scherer, A. Roche, et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET) PNAS, August 23, 2001; (2001) 191044198. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Da Silva, H. R. Tang, K. H. Wong, M. C. Wu, M. W. Dae, and B. H. Hasegawa Absolute Quantification of Regional Myocardial Uptake of 99mTc-Sestamibi with SPECT: Experimental Validation in a Porcine Model J. Nucl. Med., May 1, 2001; 42(5): 772 - 779. [Abstract] [Full Text] |
||||
![]() |
A. L. W. Bokde, P. Pietrini, V. Ibanez, M. L. Furey, G. E. Alexander, N. R. Graff-Radford, S. I. Rapoport, M. B. Schapiro, and B. Horwitz The Effect of Brain Atrophy on Cerebral Hypometabolism in the Visual Variant of Alzheimer Disease Arch Neurol, March 1, 2001; 58(3): 480 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Tang, A. J. Da Silva, K. K. Matthay, D. C. Price, J. P. Huberty, R. A. Hawkins, and B. H. Hasegawa Neuroblastoma Imaging Using a Combined CT Scanner-Scintillation Camera and 131I-MIBG J. Nucl. Med., February 1, 2001; 42(2): 237 - 247. [Abstract] [Full Text] |
||||
![]() |
M. J. de Leon, A. Convit, O. T. Wolf, C. Y. Tarshish, S. DeSanti, H. Rusinek, W. Tsui, E. Kandil, A. J. Scherer, A. Roche, et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET) PNAS, September 11, 2001; 98(19): 10966 - 10971. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |